国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
24期
3016-3018
,共3页
癌症%肺癌%血清铜%原子吸收分光光度法
癌癥%肺癌%血清銅%原子吸收分光光度法
암증%폐암%혈청동%원자흡수분광광도법
Cancer%Lung cancer%Serum Cu%AAS
目的 研究血清铜水平和不同类型癌症的关系.方法 采用原子吸收分光光度法(AAS)测定80例癌症患者及60例健康体检者血清样品中铜元素的含量.结果 癌症患者的血清铜水平[(29.87±12.02)μmol/L]较正常体检人员[(15.30±2.59)μmol/L]高,差异有极显著性(P<0.01).肺癌患者血清铜水平(41.17 μ mol/L)比鼻咽癌组(31.17μmol/L)、乳腺癌组(24.42μmol/L)、贲门癌组(31.19μmol/L)、食管癌组(29.04μmol/L)等其他类型的癌症患者高,差异有显著性(P<0.05).结论 恶性肿瘤患者血清铜水平升高,血清铜水平可作为诊断肺癌的辅助性指标.
目的 研究血清銅水平和不同類型癌癥的關繫.方法 採用原子吸收分光光度法(AAS)測定80例癌癥患者及60例健康體檢者血清樣品中銅元素的含量.結果 癌癥患者的血清銅水平[(29.87±12.02)μmol/L]較正常體檢人員[(15.30±2.59)μmol/L]高,差異有極顯著性(P<0.01).肺癌患者血清銅水平(41.17 μ mol/L)比鼻嚥癌組(31.17μmol/L)、乳腺癌組(24.42μmol/L)、賁門癌組(31.19μmol/L)、食管癌組(29.04μmol/L)等其他類型的癌癥患者高,差異有顯著性(P<0.05).結論 噁性腫瘤患者血清銅水平升高,血清銅水平可作為診斷肺癌的輔助性指標.
목적 연구혈청동수평화불동류형암증적관계.방법 채용원자흡수분광광도법(AAS)측정80례암증환자급60례건강체검자혈청양품중동원소적함량.결과 암증환자적혈청동수평[(29.87±12.02)μmol/L]교정상체검인원[(15.30±2.59)μmol/L]고,차이유겁현저성(P<0.01).폐암환자혈청동수평(41.17 μ mol/L)비비인암조(31.17μmol/L)、유선암조(24.42μmol/L)、분문암조(31.19μmol/L)、식관암조(29.04μmol/L)등기타류형적암증환자고,차이유현저성(P<0.05).결론 악성종류환자혈청동수평승고,혈청동수평가작위진단폐암적보조성지표.
Objective To study the relation between serum Cu and cancer. Methods Cu in serum is checked and measured using atomic absorption spectrophotometric(AAS)method in 80 cases of cancers, and the same trace element is measured in 60 health people. Results The level of Cu was higher in cancer patients group than of in health group, and the difference was statistical significance.(P<0.001), to contrast the level of Cu between cancer groups, the level of serum Cu in lung cancer group is higher than that of other cancer groups, such as nasopharyngeal carcinoma(P< 0.05), breast cancer( P < 0.05), cardiac cancer( P< 0.05), esophageal carcinoma(P< 0.05).Gonclusion The level of Cu is higher in cancer patients, and may be a diagnostic marker for lung cancer.
